Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial – healthradar.net

Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Diabetes drug Eli headtohead Lillys Nordisks Novo Obesity Oral outperforms Pill Trial

Previous ArticleThe Garmin Instinct Crossover AMOLED looks like a Casio G-Shock with added smarts, and I can’t wait to wear it

Next Article GOP bill extends telehealth flexibilities, sidesteps ACA subsidies

Healthradar

Leave A Reply